Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Standard Systemic Therapy with or without Definitive Treatment in Treating Participants with Metastatic Prostate Cancer


This phase III trial studies whether the addition of definitive treatment (radiation or surgical removal) of the primary tumor to standard systemic therapy for patients with prostate cancer, may help prevent the cancer from the spreading to other parts of their body. Removing the prostate by either surgery or radiation therapy in addition to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Keegan, Kirk

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: